Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2018 Q2- Text added to 2018 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
algorithm, argued, ASR, axitinib, capacity, ceftolozane, Chase, cloud, concomitantly, confirm, cystectomy, Delstrigo, description, drove, dual, duration, earliest, embedded, ESMO, EXTREME, family, free, glargine, Goldman, Greece, influenza, Inlyta, insulin, IRS, JP, lymph, meropenem, mesothelioma, metronidazole, Morgan, mortality, node, online, Pifeltro, pneumonia, prespecified, Prevnar, RCC, refused, regular, rounding, Samsung, Slovakia, software, subset, sunitinib, surgical, tazobactam, tender, tool, tract, undergo, undergone, unresponsive, urinary, ventilated, verification, visit
Removed:
ACIP, adequate, adequately, alleged, API, atypical, Australia, breach, Byetta, cessation, communicated, consistent, dismissal, failed, formulating, Gaynor, inability, inadequate, ingredient, interlocutory, male, manufactured, observed, Ohio, packaging, permission, persistent, post, posted, proceeding, promotion, proximate, randomized, reinstatement, relief, requested, requesting, responded, ruled, sexual, side, stay, testicular, trademark, UK, vaccination, Victoza, Web, week
Valuein 2018 Q2 filing- Value in 2018 Q3 filing
Original filings
Filing view